Download PDF
J Neurol Surg A Cent Eur Neurosurg 2019; 80(03): 143-148
DOI: 10.1055/s-0039-1677823
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Intraoperative Anesthesiology Management and Patient Outcomes for Surgical Revascularization for Moyamoya Disease: A Review and Clinical Experience

George W. Williams II
1   Department of Anesthesiology, University of Texas John P. and Katherine G. McGovern Medical School, Houston, Texas, United States
,
William S. Jones
2   University of Texas John P. and Katherine G. McGovern Medical School, Houston, Texas, United States
,
Rabail Chaudhry
3   Deparment of Anesthesiology, University of Toronto, Toronto, Ontario, Canada
,
Chunyan Cai
4   Department of Clinical and Translational Sciences, University of Texas John P. and Katherine G. McGovern Medical School, Houston, Texas, United States
,
Greesha S. Pednekar
1   Department of Anesthesiology, University of Texas John P. and Katherine G. McGovern Medical School, Houston, Texas, United States
,
Alia C. Long
1   Department of Anesthesiology, University of Texas John P. and Katherine G. McGovern Medical School, Houston, Texas, United States
,
Shilpa Chouhan
5   Department of Anesthesiology, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States
,
Carlos Artime
1   Department of Anesthesiology, University of Texas John P. and Katherine G. McGovern Medical School, Houston, Texas, United States
,
Robert C. Wegner
1   Department of Anesthesiology, University of Texas John P. and Katherine G. McGovern Medical School, Houston, Texas, United States
,
Navneet K. Grewal
1   Department of Anesthesiology, University of Texas John P. and Katherine G. McGovern Medical School, Houston, Texas, United States
,
Velvet M. Patterson
1   Department of Anesthesiology, University of Texas John P. and Katherine G. McGovern Medical School, Houston, Texas, United States
,
Daniel A. Contreras
1   Department of Anesthesiology, University of Texas John P. and Katherine G. McGovern Medical School, Houston, Texas, United States
,
Lara Ferrario
1   Department of Anesthesiology, University of Texas John P. and Katherine G. McGovern Medical School, Houston, Texas, United States
› Author Affiliations
Further Information

Publication History

08 February 2018

19 November 2018

Publication Date:
28 February 2019 (online)

Also available at
    Permissions and Reprints

Abstract

Background Moyamoya disease (MMD) is a rare cerebrovascular condition, often presenting as a headache or stroke in adults. Anesthetic management of this illness may challenge providers because it can affect the long-term neurologic outcome and hospital length of stay (LOS) in patients with MMD.

Materials and Methods A literature search was conducted to assess etiology and epidemiology, as well as existing reports of intraoperative management of MMD. Due to sparse findings, the search was expanded to include studies of the use of intraoperative anesthetic agents during other neurosurgical procedures. We also retrospectively reviewed all MMD cases from January 1, 2009, to December 31, 2015, at Memorial Hermann Hospital-Texas Medical Center, where intraoperative management involved craniotomy and surgical revascularization. Data were collected primarily on the use of several anesthetic agents. The LOS and any adverse events were also recorded for each case. The data were divided into two equivalent case cohorts: (1) January 1, 2009, to February 18, 2013, and (2) February 19, 2013, to December 31, 2015.

Results Remifentanil use notably increased between the first and second time periods while fentanyl use decreased. Desflurane usage also demonstrated an observed increase when our two cohorts were compared. Additionally, there was a decrease in the mean LOS between the first and second periods of 3.9 and 3.3 days, respectively.

Conclusion Increasing use of remifentanil in MMD cases could be attributed to its ability to provide more stable hemodynamics during induction, maintenance, and emergence of anesthesia when compared with fentanyl. Lower systolic pressures, diastolic pressures, and heart rates were reported in patients receiving remifentanil over fentanyl.

Keywords

moyamoya - neurosurgery - balanced anesthesia - revascularization
 

  • References

  • 1 Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009; 360 (12) 1226-1237
    CrossrefPubMedSearch in Google Scholar
  • 2 Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969; 20 (03) 288-299
    CrossrefPubMedSearch in Google Scholar
  • 3 Kamada F, Aoki Y, Narisawa A. , et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 2011; 56 (01) 34-40
    CrossrefPubMedSearch in Google Scholar
  • 4 Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 1999; 64 (02) 533-537
    CrossrefPubMedSearch in Google Scholar
  • 5 Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 2000; 15 (03) 179-182
    CrossrefPubMedSearch in Google Scholar
  • 6 Sakurai K, Horiuchi Y, Ikeda H. , et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 2004; 49 (05) 278-281
    CrossrefPubMedSearch in Google Scholar
  • 7 Mineharu Y, Takenaka K, Yamakawa H. , et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry 2006; 77 (09) 1025-1029
    CrossrefPubMedSearch in Google Scholar
  • 8 Mineharu Y, Liu W, Inoue K. , et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 2008; 70 (24 Pt 2): 2357-2363
    CrossrefPubMedSearch in Google Scholar
  • 9 Wakai K, Tamakoshi A, Ikezaki K. , et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 1997; 99 (Suppl. 02) S1-S5
    CrossrefPubMedSearch in Google Scholar
  • 10 Dutta B, Dehran M, Sinha R. Anaesthetic management of a parturient with moyamoya disease. Singapore Med J 2011; 52 (06) e108-e110
    PubMedSearch in Google Scholar
  • 11 Bacon RC, Razis PA. The effect of propofol sedation in pregnancy on neonatal condition. Anaesthesia 1994; 49 (12) 1058-1060
    CrossrefPubMedSearch in Google Scholar
  • 12 Sharma SK, Wallace DH, Sidaiwi JE, Gambling DR. Obstetric anaesthesia and moyamoya disease. Can J Anaesth 1994; 41 (08) 756-757
    PubMedSearch in Google Scholar
  • 13 Venkatesh B, Taggart PC. Anaesthetic management of a patient with moyamoya disease for Caesarean section. Can J Anaesth 1994; 41 (01) 79-80
    PubMedSearch in Google Scholar
  • 14 Chong CT, Manninen PH. Anesthesia for cerebral revascularization for adult moyamoya syndrome associated with sickle cell disease. J Clin Neurosci 2011; 18 (12) 1709-1712
    CrossrefPubMedSearch in Google Scholar
  • 15 Petty LA. Anesthetic management of a patient with moyamoya disease: a case report. AANA J 1993; 61 (03) 277-281
    PubMedSearch in Google Scholar
  • 16 Parray T, Martin TW, Siddiqui S. Moyamoya disease: a review of the disease and anesthetic management. J Neurosurg Anesthesiol 2011; 23 (02) 100-109
    CrossrefPubMedSearch in Google Scholar
  • 17 Pandey P, Steinberg GK. Neurosurgical advances in the treatment of moyamoya disease. Stroke 2011; 42 (11) 3304-3310
    CrossrefPubMedSearch in Google Scholar
  • 18 Sato K, Shirane R, Kato M, Yoshimoto T. Effect of inhalational anesthesia on cerebral circulation in Moyamoya disease. J Neurosurg Anesthesiol 1999; 11 (01) 25-30
    CrossrefPubMedSearch in Google Scholar
  • 19 Adachi K, Yamamoto Y, Kameyama E, Suzuki H, Horinouchi T. Early postoperative complications in patients with Moyamoya disease—a comparison of inhaled anesthesia with total intravenous anesthesia (TIVA) [in Japanese]. Masui 2005; 54 (06) 653-657
    Search in Google Scholar
  • 20 Ilkhchoi Y, Panikkath PV, Martin H. Moyamoya disease, revascularization surgery and anesthetic considerations. BMJ Case Rep 2014 Doi: 10.1135/bcr-2013-20284
    PubMedSearch in Google Scholar
  • 21 Schregel W, Weyerer W, Cunitz G. Opioids, cerebral circulation and intracranial pressure [in German]. Anaesthesist 1994; 43 (07) 421-430
    CrossrefPubMedSearch in Google Scholar
  • 22 Balakrishnan G, Raudzens P, Samra SK. , et al. A comparison of remifentanil and fentanyl in patients undergoing surgery for intracranial mass lesions. Anesth Analg 2000; 91 (01) 163-169
    PubMedSearch in Google Scholar
  • 23 Twersky RS, Jamerson B, Warner DS, Fleisher LA, Hogue S. Hemodynamics and emergence profile of remifentanil versus fentanyl prospectively compared in a large population of surgical patients. J Clin Anesth 2001; 13 (06) 407-416
    CrossrefPubMedSearch in Google Scholar
  • 24 Magni G, Rosa IL, Melillo G, Savio A, Rosa G. A comparison between sevoflurane and desflurane anesthesia in patients undergoing craniotomy for supratentorial intracranial surgery. Anesth Analg 2009; 109 (02) 567-571
    CrossrefPubMedSearch in Google Scholar
  • 25 About eMERGE [Electronic Medical Records and Genomics Web site]. 2014. Available at: www.emerge.mc.vanderbilt.edu/about-emerge/ . Accessed December 14, 2017
    PubMed
  • 26 MPOG Mission [Multicenter Perioperative Outcomes Group Web site]. 2017 . Available at: www.mpog.org . Accessed December 14, 2017
    PubMedSearch in Google Scholar